About the session

More than 90% of people carry at least one genetic variant that affects how they respond to common medicines, yet most prescribing still relies on trial and error. Pharmacogenomics (PGx) testing gives clinicians a clearer picture of how an individual is likely to respond, helping to reduce adverse drug reactions and avoid ineffective treatment.

Join Mantara Health and the Independent Doctors Federation for a practical look at how PGx fits into everyday independent practice:

  • The evidence behind PGx, including the PREPARE study published in The Lancet, which found a 30% reduction in clinically relevant adverse drug reactions with genotype-guided prescribing
  • Which medicines and specialties benefit most, from clopidogrel to antidepressants, statins and pain relief
  • How testing works: a simple saliva sample, turnaround and how results are reported
  • Access and reimbursement, with CCSD codes now in place for both the full PGx panel and the clopidogrel test
  • Q&A, with time to discuss your own patients and practice

Breakfast is served from 9:00am. Places are limited, so please register early.

Who should attend

The session is designed for clinicians and healthcare leaders who prescribe, dispense or shape how medication is managed, including:

  • Private GPs and concierge medicine doctors
  • Consultants, particularly in cardiology, psychiatry, pain medicine and general medicine
  • Pharmacy owners, superintendent pharmacists, and clinical and community pharmacists
  • Primary care executives and leaders, including PCN and practice leadership teams
  • Employee wellbeing, occupational health and corporate health leads
  • Clinic owners and medical directors considering adding PGx testing to their services

No prior knowledge of genetics is needed. You'll leave with a clear understanding of when to test, how to read a PGx report and how testing could fit into your practice, pharmacy or organisation.

Running order

  • Arrival and breakfast: Coffee, breakfast and time to meet colleagues

  • Welcome: Introduction from the Independent Doctors Federation

  • Personalised medicine in practice: Dr Mark Hudson-Peacock on the evidence, the tests and real patient cases

  • Q&A and discussion: Bring your questions and your own prescribing challenges

  • Close: Informal follow-up conversations with the Mantara team

Dr Mark Hudson-Peacock

Dr Mark Hudson-Peacock

Founder/Chairman & CEO, Mantara Health

Find out more